1 BIOLASE Analyst Ratings, Earnings, Dividends and Insider Trades | $BIOL | NASDAQ:BIOL | Analyst Ratings Network

Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BIOLASE Company Profile (NASDAQ:BIOL)

Consensus Ratings for BIOLASE (NASDAQ:BIOL) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $3.42 (45.39% upside)

Analysts' Ratings History for BIOLASE (NASDAQ:BIOL)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/12/2013WallachBeth CapitalLower Price TargetBuy$3.50 -> $2.75ViewTweet This Rating  Share This Rating on StockTwits
10/8/2013ZacksUpgradeUnderperform -> Neutral$2.00ViewTweet This Rating  Share This Rating on StockTwits
9/12/2013SidotiUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
9/2/2013ZacksDowngradeNeutral -> Underperform$1.60ViewTweet This Rating  Share This Rating on StockTwits
8/8/2013WallachBeth CapitalLower Price TargetBuy$6.50 -> $4.50ViewTweet This Rating  Share This Rating on StockTwits
7/3/2013Ascendiant Capital MarketsReiterated RatingBuy$6.50 -> $5.50ViewTweet This Rating  Share This Rating on StockTwits
6/17/2013WallachBeth CapitalReiterated RatingBuy$6.50ViewTweet This Rating  Share This Rating on StockTwits
4/23/2013Ascendiant Capital MarketsInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
3/18/2013Northland SecuritiesBoost Price TargetOutperform$6.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
3/7/2013Northland SecuritiesBoost Price TargetOutperform$6.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
9/7/2012Northland SecuritiesInitiated CoverageOutperform$4.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/17/2012 forward)